News

News

Press Releases

Mar 01, 2022
Tricida to Participate in Cowen 42nd Annual Health Care Conference
SOUTH SAN FRANCISCO, Calif. , March 01, 2022 (GLOBE NEWSWIRE) -- Tricida, Inc. (Nasdaq: TCDA), a pharmaceutical company focused on the development and commercialization of its investigational drug candidate, veverimer, a non-absorbed, orally-administered polymer designed to slow chronic kidney